Wilson Sonsini Goodrich & Rosati advised Pure Lithium on the transaction. Pure Lithium Corporation, a disruptive Boston-based vertically integrated lithium metal battery technology company, announced the...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Radar Therapeutics on the deal, and Wilson Sonsini Goodrich & Rosati advised Radar Therapeutics on IP matters related...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Mirus Bio and Gamma Biosciences on patent matters related to the transaction. and Sidley Austin represented Gamma. Gamma Biosciences, a...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Pascal on IP matters related to this transaction. Pascal announced it has raised an $8 million seed round led by...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Pure Lithium on the transaction. Pure Lithium announced it secured $15 million in a Series A financing led by Oxy Low...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Adela on patent matters related to the transaction. Adela, Inc. announced the completion of a $48 million financing. The round included existing...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Delve Bio in the transaction. Delve Bio announced it has debuted with $35 million in Series A financing led by Perceptive...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Aspect Biosystems on the transaction. Aspect Biosystems, a biotechnology company pioneering the development of bioprinted tissue therapeutics, and leading global...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Novo Holdings and Metagenomi on the deal. Fenwick represented Metagenomi. Gene editing company Metagenomi announced a $100 million Series B...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised Replay on the deal. Replay, a genome writing company reprogramming biology by writing and delivering big DNA, announced its launch with $55 million...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented ReCode Therapeutics in the transaction. ReCode Therapeutics, a genetic medicines company using superior delivery to power the next wave of...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Mirvie on the deal. Mirvie, a pioneer in predicting unexpected pregnancy complications, announced it has raised $60 million in a...
You must be a Standard 1 Year member to access this content.
